BN104 in Combination With Chemotherapy or Targeted Agents for Acute Myeloid Leukemia

Clinical trial NCT06746519 · RECRUITING

Trial details

NCT number: NCT06746519
Sponsor: Chen Suning
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2024-12-25
Primary completion: 2025-12-30
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.